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Inflammatory bowel disease (IBD), manifested clinically by 
bloody diarrhea, abdominal cramps, and pain, is an immunologically 
mediated relapsing and chronic disease that affects the intestinal 
mucosa.[1] Patients with IBD are also at a higher risk to develop 
colorectal cancer, when compared to the average population.[2] 
Crohn’s disease (CD) and ulcerative colitis (UC) represent the two 
most common forms of IBD.[1,2] These diseases mimic each other 
in symptoms and some mucosal pathology, but differ sufficiently 
to be considered as independent ailments.[1] The etiology and the 
exact disease mechanisms remain unknown despite much effort and 
research.[2] It is well known that the incidence of IBD is high in the 
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countries of North America, and northern and western Europe, while 
it is low in Africa, eastern Europe, South America, Asia, and the Pa‑
cific region. Conversely, recent studies indicate that the incidence has 
stabilized or slightly increased in countries with a high prevalence 
previously, while it is on the rise in countries with a low incidence 
previously. Jointly, these reports indicate that IBD could be a global 
health problem in the future and understanding its pathogenesis and 
developing affordable safe treatment is important.[3]
CURRENT STATUS OF KNOWLEDGE
Molecular events responsible for UC
From a clinical perspective, the central sign of UC is inflam‑
mation of the mucosal lining of the colon and mechanistically, 
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this end event is a result of interplay between various molecu‑
lar constituents of the cells. The inflammatory pathway in UC 
involves ubiquitous expression of proinflammatory eukaryotic 
transcription factors [activator protein (AP)‑1 and nuclear factor 
kappa‑light‑chain‑enhancer of activated B cells (NF‑κB)],[4,5] 
which leads to the production of pro‑inflammatory cytokines like 
tumor necrosis factor (TNF)‑α, interleukin (IL)‑6, IL‑1β, with 
T‑helper (Th)‑17 cytokines such as IL‑23 and IL‑17 predominating, 
and a concomitant decrease in the anti‑inflammatory cytokines and 
proteins.[6,7] This surge in pro‑inflammatory cytokines is followed 
by an increase in the production of cyclooxygenase (COX)‑2, 
inducible nitric oxide synthase (iNOS), myeloperoxidase,[8] and 
signal transducer and activator of transcription[9] ‑3,[5,6] which 
further increases inflammation and leads to oxidative stress[10] 
and a concomitant decrease in the level of antioxidants.[10,11] All 
these events lead to an increase in cell inflammation, infiltration 
of the immune cells, especially the neutrophils, and culminate 
into epithelial cell damage and colonic barrier dysfunction. UC 
is also an established risk for colon cancer, which is caused due 
to the repeated cycle of inflammation leading to spontaneous 
mutation in the DNA repair mechanism, oncogenes, and tumor 
suppressor genes like p53.[4,5] Another factor responsible for the 
development of UC is the change in the constituent, number, and 
activity of the colon microflora, as studies with germ‑free mice 
have conclusively shown less or no inflammation developing in 
chemical and genetic models of colitis.
Conventional treatments in UC
Chemotherapy has been the mainstay of treatment of UC; 
in the event of a mild disease, anti‑inflammatory drugs such as 
sulfasalazine and 5‑aminosalicylic acid are given, while in severe 
and chronic cases, treatment with rectal and systemic corticoste‑
roid and immunosuppressant is administered.[12] In most cases, 
the benefits are restricted to the reduction of inflammation and its 
complications.[1] However, in extreme conditions, surgery is the 
last solution to the patient’s condition. Conversely, regular intake 
of these medications is unsafe as they may have severe side effects 
such as gastric ulcers, Cushing’s habitus, hyperglycemia, muscle 
weakness, fragile skin, purple striae, flaring up of latent infections, 
delayed wound healing, cataract, osteoporosis, glaucoma and 
hypothalamic pituitary axis suppression with corticosteroids, and 
an increased risk of opportunistic infections and development of 
lymphomas.[1] In addition, some refractory condition can lead to 
severe morbidity and decrease in the quality of life.[1]
Recently, biologics such as anti–TNF‑α, anti–alpha‑4 integ‑
rin, as well as Peroxisome proliferator‑activated receptor gamma 
(PPARγ) ligand and probiotic therapy are being used, but their 
long‑term benefits are unknown.[1] Importantly, reports suggest 
that the long‑term use of biologics, especially infliximab, adali‑
mumab, and certolizumab, may increase the risk of infections 
and malignancies, especially non‑Hodgkin’s lymphoma.[13] Drugs 
that block leukocyte adhesion such as natalizumab, those that 
target cytokines, like IL‑ 12/23, and antibodies inhibiting T‑cell 
signaling, such as IL‑6 receptor antibodies, are also being studied. 
However, these drugs also have a number of contraindications and 
side effects, especially when used in combination with classical 
immunosuppressive drugs. The major effects are opportunistic 
infections, malignancies, and diverse complications like injection/
infusion reactions and autoimmunity, and contraindications such 
as heart failure and acute infectious diseases.[14]
The repeated relapses, surgery phobia, severe morbidity, and 
derisory response to conventional drugs make the patient to resort 
to unconventional treatments with a hope to decrease the symptoms 
of the disease and concomitantly perk up the quality of life.[15] 
Recent reports indicate that at least 40% of IBD patients have used 
complementary and alternative medicines, and that the botanicals 
constitute a major share of all these alternatives.[15]
Results from preclinical studies suggest the beneficial ef‑
fect of medicinal plants including Aloe vera gel (蘆薈 Lú Huì), 
Boswellia serrata (乳香 Rǔ Xiāng), Cassia fistula, Lepidium sati-
vum, Bunium persicum, Plantago ovata, Pistacia lentiscus, Bunium 
persicum, Solanum nigrum, Commiphora mukul, Commiphora 
myrrha, Ocimum basilicum (羅勒 Luó Lè), Linum usitatissimum, 
Dracaena cinnabari, Plantago major, Lallemantia royleana, and 
Allium porrum, which have been used since time immemorial in 
the various systems of traditional and folk medicine.[16,17]
From human perspective, it is always desirable to consume 
dietary agents that also possess medicinal value as their regular 
use can be achieved easily and regularly. This aspect was very 
well recognized by Hippocrates, the Father of Medicine, who 
proclaimed almost 25 centuries ago, “Let food be thy medi-
cine and medicine be thy food.” To further substantiate the impor‑
tance and relevance of this adage, observations from around the 
world clearly indicate that the incidence of diet‑related diseases is 
progressively increasing due to greater availability of hypercaloric 
food and a sedentary lifestyle, which  cause low‑grade inflamma‑
tion in the individual.[18]
Recent reports also suggest that the functional foods and nutra‑
ceuticals rich in polyphenols and antioxidants are beneficial due to 
their intrinsic ability to scavenge free radicals, induce anti‑inflam‑
matory responses, maintaining a homeostatic regulation of the gut 
microbiota, and activate the intestinal T regulatory cells.[18] All these 
properties are extremely beneficial in the prevention and mitigation 
of the IBD. Studies have  shown that the dietary agents like apple, 
bilberry, black raspberry, cocoa, bael, green tea (綠茶 Lǜ Chá); 
spices like garlic (大蒜 Dà Suàn), Malabar tamarind, saffron 
(番紅花 Fān Hóng Huā), fenugreek, ginger (生薑 Shēng Jiāng), 
turmeric (薑黃 Jiāng Huáng); oil of olive; nutraceuticals like grape 
seed polyphenols; and the dietary phytochemicals like resveratrol, 
ellagic acid, zerumbone, quercetin, kaempferol, rutoside, and rutin are 
consumed regularly and are commonly used. They will be addressed 
in detail by emphasizing on the mechanism of action.
DIETARY AGENTS WITH ANTI‑IBD EFFECTS
Apple
Apple, known as Malus malus, belongs to the family Rosaceae 
and is an important dietary agent.[19‑21] It has occupied a prime 
position in the dietary and nutritional requirements of humans and 
epidemiological studies have linked its consumption with reduced 
risk of certain cancers, cardiovascular diseases, asthma, and diabe‑
tes.[21] Apple is a good source of several flavonoids and certain phy‑
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tochemicals including quercetin glycosides, catechin, epicatechin, 
procyanidin, cyanidin‑3‑galactoside, coumaric acid, chlorogenic 
acid, gallic acid, and phloridzin.[22] Recently, D’Argenio et al. 
found that rectal administration of apple polyphenols protected rats 
from 2,4,6‑trinitrobenzene sulfonic acid (TNBS)‑induced colitis by 
decreasing the transcription and protein levels of COX‑2, TNF‑α, 
calpain, as well as tissue transglutaminase. Thus, polyphenolic 
compounds obtained from apple may serve as potential therapeutic 
agents for UC patients.[23]
Bilberry
Bilberry, also known as blaeberry (a Scottish name meaning 
blueberry), mountain bilberry, whinberry, whortleberry, whortles, 
myrtle whortleberry, tracleberry, and huckleberry, is a plant indig‑
enous to Europe and has long been consumed in jams, pies, cob‑
blers, and cakes.[24,25] Its scientific name is Vaccinium myrtillus L. 
and it belongs to the family Ericaceae. Phytochemical studies have 
shown it to contain the flavonoids like hyperoside, isoquercitrin, 
quercitrin, and astragaline and the anthocyanins like myrtillin, 
malvidin, cyanidin, delphinidin, and tannins.[26]
Bilberry has been used to treat ocular disorders and is believed 
to be useful in improving night vision, prevent the development 
and progression of cataracts, treat diabetic retinopathy and macular 
degeneration, and prevent glaucoma.[26,27] With respect to its use in 
UC, an open pilot trial by Biedermann and coworkers with 13 indi‑
viduals with UC has shown that the daily intake of a standardized 
bilberry preparation caused 63.4% remission and 90.9% response 
in the volunteers. Intake of the bilberry preparation decreased the 
total Mayo score and the histologic Riley index.[28] However, an 
increase in disease activity was observed after cessation of bilberry 
intake, clearly indicating the beneficial effects of bilberries in UC, 
but only when taken regularly.
Black raspberry
The fruits of the perennial shrub Rubus coreanus Miquel, 
colloquially known as black raspberry, have been an important 
dietary and medicinal agent in traditional medicine.[29‑31] The 
plants grow in Far East Asian countries, namely South Korea, 
Japan, and China.[32] The anthocyanin fraction of black raspberry 
has been found to be protective against esophageal and colorectal 
cancer.[31] Montrose and coworkers investigated the protective ef‑
fects of freeze‑dried black raspberry powder on dextran sodium 
sulfate (DSS)–induced UC in C57BL/6J mice and observed it to 
be effective in ameliorating the clinical conditions.[33] The mice 
fed with black raspberry powder showed better maintenance of 
body mass and reduction in colonic shortening and ulceration. 
They had reduced levels of plasma prostaglandin E2 (PGE2), 
while the levels of nitric oxide (NO) were unaltered.[33] Feeding 
black raspberry powder suppressed the tissue levels of COX‑2 
and key pro‑inflammatory cytokines like TNF‑α and IL‑1β.[33] 
Mechanistic studies within the colonic tissue showed decreased 
levels of phospho‑IκBα indicating that black raspberry powder 
modulated the NF‑κB, supporting its possible therapeutic or 
preventive role in the pathogenesis of UC and related neoplastic 
events. With respect to phytochemicals, experiments have also 
shown that ellagic acid [Figure 1], which is present in raspberries 
and other berries like blackberries, cranberries, strawberries, and 
wolfberries, possesses concentration‑dependent protective effects 
against the DSS‑induced colitis in rats.[34]
Cocoa
Cocoa, known as Theobroma cacao, is a small evergreen tree 
native to South America.[35,36] Its seeds are used to make cocoa 
powder and chocolate, and are widely used in confectionery 
industry.[37] Furthermore, the seeds also contain polyphenols and 
flavonoids that possess several health benefits.[38] Andújar et al. 
found the polyphenol‑enriched cocoa extract containing epicat‑
echin, procyanidin B2, catechin, and procyanidin B1 to possess 
anti‑inflammatory properties against DSS‑induced colitis in mice. 
This effect was manifested by reduction in inflammation, crypt 
damage, and leukocyte infiltration in the mucosa due to decrease 
in the production of NO, COX‑2, phospho‑STAT‑3 (pSTAT‑3), 
pSTAT1α, and NF‑κB p65. Similar results have been found 
in vitro using RAW 264.7 cells, indicating that cocoa extract is 
effective in ameliorating DSS‑induced colitis and the effect may 
be mediated by the inhibition of transcription factor NF‑κB in 
intestinal cells.[39] A clinical trial by Monagas et al.[40] concluded 
that cocoa polyphenol intake modulated inflammatory mediators 
in patients with a high risk of cardiovascular disease and could 
be beneficial against atherosclerosis.[40] These anti‑inflammatory 
effects may contribute to the overall benefits of cocoa consump‑
tion against atherosclerosis. However, a study by Pérez‑Berezo 
et al. showed that cocoa may be effective in reducing oxidative 
stress by downregulating serum TNF‑α and iNOS activity in the 
colon or by increasing reduced glutathione (GSH), but this is not 
enough to reverse the DSS‑induced colitis in the mice model. They 
concluded that cocoa intake may decrease colon cell infiltration and 
inflammation to a certain extent, but not completely.[41] Therefore, 
it becomes imperative to perform more experimental and clinical 
studies to get a verdict for the use of cocoa in the treatment of 
colitis before its usage as a complimentary medicine.
Bael
Aegle marmelos, commonly known as holy fruit, Bengal 
quince, Indian quince, golden bael, or bilva, is arguably one 
of the most important plants in ancient India.[42] The plants are 
indigenous to India, and contain tannins, some essential oils like 
caryophyllene, citral, sterols, and/or triterpenoids, flavonoids like 
rutin and coumarins, including aegeline, marmesin, phlobatannins, 
flavon‑3‑ols, leucoanthocyanins, and anthocyanins[42,43] [Figure 1]. 
In Ayurveda, the Indian traditional system of medicine, bael is 
utilized for its ability in the treatment of various diseases includ‑
ing diarrhea, dysentery, and dyspeptic symptoms.[44] With regard 
to IBD, recent studies by Behera et al. have shown bael to be 
effective in ameliorating acetic acid‑induced UC and indometha‑
cin‑induced enterocolitis in Wistar albino rats. The investigators 
observed that oral administration of the Bael fruit extract caused 
a significant decrease in disease activity index, macroscopic 
score, and microscopic scores. Mechanistic studies showed that 
administering Bael caused reduction in mast cell degranulation 
and malondialdehyde (MDA) levels and increased superoxide 
dismutase (SOD) activity.[45]
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Green tea (綠茶 Lǜ Chá)
Tea (Camellia sinensis), a plant native to China and Southeast 
Asia, is today the most commonly used botanical globally.[46,47] It 
is the second most widely consumed beverage after water, and 
may be consumed as green tea (unfermented), oolong tea (par‑
tially fermented), and black tea (fully fermented). Many studies 
carried out in the past three decades have shown that green tea 
possesses myriad benefits owing to its polyphenol content.[48‑50] 
The active compounds of green tea are the catechins [(–)‑epicat‑
echin (EC), (–)‑epigallocatechin (EGC), (–)‑epicatechin‑3‑gal‑
late (ECG), and (–)‑epigallocatechin‑3‑gallate (EGCG)] [Figure 1], 
proanthocyanidins, flavonols (kaempferol, quercetin, and myricitin 
in the form of glycosides), gallic acids, and theanine.[51]
Animal studies have proved that use of green tea polyphe‑
nol (GrTP) ameliorated the symptoms associated with colitis 
induced by DSS,[52] dinitrobenzene sulfonic acid (DNBS),[53] and 
in IL‑2 deficient mice.[54] These include bloody diarrhea, weight 
loss, wet colon weights,[55] colonic damage, hemorrhage, ulcers, 
edema, and neutrophil infiltration.[55] Experiments also revealed 
that GrTP prevented acute colitis and inflammation‑associated 
colon carcinogenesis in male ICR mice.[56] Furthermore, the 
phytochemical EGCG reduced DSS‑[57] and TNBS‑induced colitis 
in rats[58] and mice.[55]   Moreover, treatment with green tea had 
significantly less impact on the hematocrit,[52,54] serum amyloid 
A,[52,54] and blood GSH[52] in animals after colitis induction, indi‑
cating an improvement in the animal health with the antioxidant 
administration.
Further, GrTP decreased spontaneous interferon‑gam‑
ma (IFN‑γ) and TNF‑α secreti on from the colon explant in IL‑2 
deficient animals when compared to their control counterparts,[54] 
and reduced the levels of TNF‑α,[52,53,55] IL‑6, IL‑10, and the 
keratinocyte‑derived chemokine,[55] which further reflects reduc‑
tion of inflammation by GrTP administration. Administration 
of the polyphenol EGCG also led to a decrease in the levels of 
COX‑2,[58] myeloperoxidase,[8,53,55] and intercellular adhesion 
molecule‑1 (ICAM)‑1,[53] and rectified the distorted actin cyto‑
skeleton in the colonic tissue.[52] These beneficial effects of EGCG 
were associated with a significant reduction of NF‑κB and AP‑1 
activation.[55] The phytochemicals EGCG and Polyphenon E also 
attenuated inflammation‑induced colon cancer caused by DSS and 
azoxymethane (AOM) and the protective effects were mediated 
by reducing COX‑2 and the mRNA expression levels of TNF‑α, 
IFN‑γ, IL‑6, IL‑12, and IL‑18 in the colonic mucosa.[59] Further, 
treatment with a combination of EGCG and piperine reduced body 
weight loss, improved the clinical course, and increased the overall 
survival, when compared to untreated groups.[57] The attenuated 
colitis was associated with lower histological damage and colon in‑
sult, reduction in lipid peroxidation, decreased levels of MPO, and 
a concomitant increase in the levels of antioxidant enzymes [SOD 
and glutathione peroxidase (GPx)] in the colonic tissue.[57] A recent 
study by Oz et al.[60] has shown the protective effect of different 
dosages of GrTP (0.25%, 0.5%, and 1%), EGCG (0.12%, 0.25%, 
and 0.5%), and a single dosage of sulfasalazine (50 mg/kg) in 
experimental colitis model. They found that GrTP and EGCG 
improved hematocrit values, as compared to sulfasalazine which 
caused anemia. Also, low dose of EGCG reduced colonic patho‑
logical lesions and normalized global antioxidant ratio, but was 
least beneficial in inhibiting reduction of leptin levels. However, 
GrTP partially protected animals against weight loss and elevated 
TNF‑α. This study concluded that low‑dose EGCG and GrTP may 
become potential therapeutic or additive agents in the treatment 
of IBD; however, clinical trials are warranted to prove this.[60]
However, seminal studies by Inoue et al.[61] have provided evi‑
dence that oral treatment of 1% GrTP to both normal and colitic 
Figure 1. Chemical structures of some phytochemicals effective against UC
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animals induced nephrotoxicity in the ICR mice. The investiga‑
tors observed that 1% GrTP given to colitic mice significantly 
increased their kidney weight and increased the levels of serum 
creatinine and thiobarbituric acid reactive substances (TBARS), 
but decreased the expression of heme oxygenase‑1 (HO‑1), 
NAD (P) H: Quinone oxidoreductase 1 (NQO1), and heat‑shock 
protein (HSP) 90 in both kidney and liver, as compared to the 
colitic mice treated with the standard diet.[61] Antioxidant en‑
zymes’ mRNA expression and HSPs, such as HO‑1, HSP27, 
and HSP90, were significantly down‑regulated in the colitic 
mice receiving 1% GrTPs.[61] It is noteworthy that these results 
clearly indicate that high‑dose GrTP diet disrupts kidney func‑
tions through the reduction of antioxidant enzymes and HSP 
expression in both treated and untreated control ICR mice.[61] In 
clinical studies, green tea has been shown to provide antioxidant 
protection in metabolic syndrome[62] and has shown a positive 
effect on blood pressure, insulin resistance, inflammation, and 
oxidative stress in patients with obesity‑related hypertension.[63]
Grapes
In the history of mankind, grapes (Vitis vinifera) have been 
one of the most important fruits due to their importance in win‑
ery.[64] The major constituents of grape are  epicatechin gallate; 
procyanidin dimers, trimers, tetramers; catechin; epicatechin; 
gallic acid; procyanidin pentamers, hexamers, and heptamers and 
their gallates; resveratrol; phenolics; flavonoids; and anthocya‑
nins [Figure 2].[65] Grapes possess anti‑inflammatory, anti‑aging, 
potent antioxidant, antimutagenic, antidiabetic, hepatoprotective, 
cardioprotective, nephroprotective, neuroprotective, and anti‑car‑
cinogenic properties.[65] Pre‑clinical studies provided evidence that 
polyphenols from grape seed are effective in reducing TNBS‑[66,67] 
and DSS‑induced colitis in rats,[68] with the protective effects being 
equal to those of the clinically used drug.[66]
Administering grape seed proanthocyanidin extract (GSPE) 
reduced the macroscopic and microscopic damage scores and 
changes in weight/length ratio (mg/mm) of colon segments, when 
compared with standard diet in rats.[66,67] Studies have also shown 
that when compared to DSS‑treated controls, GSPE significantly 
decreased ileal villus height and mucosal thickness toward the 
values of normal controls.[68] In addition, GSPE significantly re‑
duced the histological severity score only in the proximal colon 
and failed to prevent crypt damage of both proximal and distal 
colonic regions of the DSS‑treated rats.[68]
Mechanistic studies revealed that the levels of MDO[66,67] 
and NO,[67] activities of MPO[66,67] and iNOS,[67] and the levels of 
inflammatory cytokines like IL‑1β[66] were reduced in the colon 
tissues and serum of the GSPE‑treated rats as compared to colitis 
control group.[66] Furthermore, grape seed polyphenol treatment 
was associated with notably increased SOD and GPx activities and 
also the glutathione level[67,69] of colon tissues and serum of rats. 
The levels of IL‑2 and IL‑4[66] were also found to be significantly 
increased. GSPE significantly reduced the expression levels of 
TNF‑α,  phospho‑Inhibitor of nuclear factor kappa‑B kinase 
subunit alpha/beta (p‑IKKα/β), and 9phospho‑nuclear factor of 
kappa light polypeptide gene enhancer in B‑cells inhibitor, alpha 
(p‑IκBα), and the translocation of NF‑κB in the colon mucosa. 
Administration of GSPE did not negatively impact metabolic 
parameters, nor did it induce any deleterious gastrointestinal 
side effects in healthy animals.[68] Thus, it can be concluded that 
GSPE exerts a protective effect on colitic rats by modulating the 
inflammatory response locally and systemically, and promotes 
tissue repair to improve colonic oxidative stress, at least in part 
by modulating the NF‑κB signaling pathway.[69]
Olive oil
The oil extracted from the fruits of the olive tree (Olea euro-
paea) is one of the highly investigated dietary agents in recent 
times, and studies suggest that it possesses a wide range of thera‑
peutic applications.[70‑72] The trees are native to the Mediterranean 
basin and parts of Asia Minor, and are mentioned in the ancient 
literature from Biblical and Roman times to Greek mythology. 
Olive oil is a major component of the Mediterranean diet and 
many beneficial effects of this diet have been attributed to the 
ample use of the oil. The chief active components of olive oil 
include oleic acid, phenolic constituents, and squalene. The main 
phenolics include hydroxytyrosol, tyrosol, and oleuropein, which 
occur in highest levels in virgin olive oil and have demonstrated 
antioxidant activity.[72]
Seminal studies by Sánchez‑Fidalgo and coworkers have 
shown that the olive oil attenuates DSS‑induced acute UC[73‑75] 
and DSS‑colitis‑associated colon carcinogenesis in mice.[76] The 
active phytochemical hydroxytyrosol was also shown to be effec‑
tive in reducing the DSS‑induced damage.[74] The investigators 
observed that administering diets enriched with extra virgin olive 
oil (EVOO) significantly reduced the DSS‑induced mortality by 
nearly 50%, attenuated the clinical and histological signs of dam‑
age, and improved the disease activity index.[74]
Mechanistic studies have shown that administering EVOO 
reduces the damage in acute colitis model by alleviating the 
oxidative stress. It prevents the degradation of IκBα, deacti‑
vates PPARγ, down‑regulates the expression of iNOS, COX‑2, 
monocyte chemoattractant protein‑1 (MCP‑1), and TNF‑α, and 
activates p38 mitogen‑activated protein kinases (MAPKs) in the 
colonic mucosa.[73,74] Observations from the DSS‑colitis–associated 
carcinogenesis experiments also suggest that the feeding EVOO 
reduced the incidence and multiplicity of dysplastic lesions due 
to reduced β‑catenin and decreased levels of COX‑2, iNOS, and 
other proinflammatory cytokines.[76]
Agaricus blazei
Agaricus blazei Murill, an edible mushroom indigenous to 
Brazil, is a rich source of a variety of β‑glucans, proteoglucans, 
glycoproteins, saponins, tannins, cerebrosides, polysaccha‑
rides, and steroids. It is one of the most important edible and 
culinary medicinal species.[77,78] It is cultivated commercially 
for the health food market and is shown to possess a range 
of medicinal properties against diseases like cancer[79,80] and 
chronic hepatitis.[81] Preclinical studies have shown it to pos‑
sess anti‑inflammatory effects against a range of ulcerogens.[78] 
With respect to its beneficial effects in the treatment of IBD, 
a recent clinical study has shown that consumption of 60 ml/
day of immunomodulatory extract (AndoSan™) at a concentra‑
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tion of 340 g/l or 20.4 g/day for 12 days caused reduction in 
the levels of pro‑inflammatory cytokines like IL‑1β and IL‑6 
and chemokines like IL‑8, Macrophage inflammatory protein 
(MIP‑1β), Monocyte chemoattractant protein‑1 (MCP‑1), 
Granulocyte macrophage colony‑stimulating factor (GM‑CSF), 
and Granulocyte colony‑stimulating factor (G‑CSF)  in UC and 
CD patients, indicating a reduction in inflammation. Levels of 
fecal calprotectin were also reduced in UC patients, with an 
overall reduction in IBD pathology.[82]
Indian gooseberry
Indian gooseberry or amla, scientifically known as Emblica 
officinalis Gaertn. or Phyllanthus emblica Linn., is an indigenous 
plant of India.[83] The fruits are a rich source of ascorbic acid and the 
juice prepared from the ripe fruits is an excellent coolant in the hot 
summer season.[84] The fruits also contain gallic acid, ellagic acid, 
chebulinic acid, chebulagic acid, emblicanin‑A, emblicanin‑B, 
punigluconin, pedunculagin, ellagitannin,  trigalloyl glucose, 
chebulagic acid, corilagin, quercetin, kaempferol 3‑O‑α‑l (6’’ 
methyl) rhamnopyranoside, and kaempferol 3‑O‑α‑l (6’’ ethyl) 
rhamnopyranoside.[84]
Amla is arguably the most important medicinal botanic in the 
traditional Indian system of medicine, the Ayurveda. Studies have 
shown it to possess antibacterial, antifungal, antiviral, free radical 
scavenging, anti‑mutagenic, anti‑inflammatory, cardioprotective, 
gastroprotective, hepatoprotective, nephroprotective, neuroprotec‑
tive, and anticancer properties.[84] A recent study by Deshmukh 
et al.[93] has shown that the methanolic extract of E. officina-
lis (200 mg/kg) was effective in ameliorating the severity of acetic 
acid–induced colitis in rats.[85] It reduced colon weight/length ratio, 
colon insult, and macroscopic scores for inflammation, in addition 
to lactate dehydrogenase (LDH), indicating that amla protected 
against the inflammogen and possessed cytoprotective effects.[85]
SPICES WITH ANTI‑IBD EFFECTS
Spices, which are termed as aromatic vegetable substances, 
in the whole, broken, or ground form, and whose significant 
function in food is seasoning rather than nutrition, are an im‑
portant constituent of the Indian curries.[86,87] In addition to their 
organoleptic properties, spices are also useful in prolonging the 
shelf life of foods by preventing rancidity through their free 
radical scavenging effects and also by imparting antimicrobial 
activities.[86,87] Historical reports also support the fact that ancient 
physicians like Charaka, Sushrutha, Hippocrates, and Dioscorides 
used spices extensively in their practice.[87] Additionally, most 
of the spices also possess medicinal benefits and are extensively 
used to treat various gastrointestinal ailments.[86, 87] In the follow‑
ing section, the beneficial effects of spices like garlic, saffron, 
Malabar tamarind, fenugreek, ginger, and turmeric [Figure 3] will 
be addressed in detail.
Garlic (大蒜 Dà Suàn)
Garlic, scientifically known as Allium sativum and a member 
of the Liliaceae family, is highly regarded throughout the world 
for both its medicinal and culinary value.[88] The plant is indig‑
enous to Asia and historical documents suggest that the early men 
of medicine such as Hippocrates, Pliny, and Aristotle  used this 
botanical for its numerous therapeutic  uses, and it is regularly 
used in various traditional and folk medicines.[88] In traditional 
medicines, garlic, both raw and aged, is used as a natural antiviral, 
antibacterial, and antifungal agent, to suppress common cough,[89] 
to treat gastrointestinal disorders,[90] and to act as a cardiopro‑
tective agent.[91,92] Different types of antioxidants are present in 
different garlic preparations, including water‑ and lipid‑soluble 
organosulfur compounds like S‑allylcysteine and S‑allylmercap‑
tocysteine[93] and non‑metals like selenium and phytoalexin‑like 
Figure 2.  Some phytochemicals present in grape seed
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allixin, which are responsible for the protective effect of garlic 
in several disease models.[94,95] Rats fed garlic (0.25 g/kg b. 
wt.) orally for 4 weeks and 3 days during acetic acid–induced 
colitis  showed a significant reduction  in colon weight. Garlic 
administration restored the levels of GSH and antioxidant en‑
zymes with a concomitant decrease in lipid peroxidation levels, 
as compared to placebo‑treated colitis groups. Also, garlic treat‑
ment in the presence of the amino acid l‑arginine (625 mg/kg b. 
wt.) mitigated the changes in both colon weight and colon tissue 
contents of lipid peroxidation and GSH.[92]
Ginger (生薑 Shēng Jiāng)
Ginger, a plant native to the northeast region of India, is one 
of the world’s most important culinary and medicinal agents in 
various alternative systems of medicines.[96‑98] Some of the impor‑
tant bioactive components of ginger extract include 10‑gingerol, 
8‑gingerol, 6‑gingerol, and 6‑shogaol, with 6‑gingerol being 
antiproliferative.[99] It has been documented to treat cold, head‑
aches, nausea, stomach upset, diarrhea, and helps digestion, treats 
arthritis, rheumatological conditions, and muscular discomfort, 
and acts as a carminative and antiflatulent.[100] Scientific studies 
have shown that ginger possesses antimicrobial, antischistosomal, 
anti‑inflammatory, antipyretic, antioxidative, hypoglycemic, 
hepatoprotective, diuretic, and hypocholesterolemic effects.[101]
Preclinical studies have shown that pretreatment with ginger 
extract ameliorated the acetic acid–induced edematous inflam‑
mation in the colon by significantly attenuating the extent and 
severity of edema, necrosis, and inflammatory cell infiltration 
in the mucosa.[102] The activity of colonic MPO and levels of 
lipid peroxides, protein carbonyl content, TNF‑α, and PGE2 
were also decreased. Administering ginger restored the levels 
of GSH, catalase (CAT), and SOD. The protective effect of 
highest doses of ginger was comparable to that of the standard 
sulfasalazine.[102]
In addition, studies have also shown that zerumbone (a ses‑
quiterpenoid) [Figure 1], a minor constituent of Zingiber of-
ficinale but a major component of Zingiber zerumbet, mitigated 
the DSS‑induced acute colitis in ICR mice.[103] Oral feeding of 
zerumbone reduced the inflammatory biomarkers (IL‑1α, IL‑1β, 
TNF‑α, PGE2, and PGF2α) in the colonic mucosa and suppressed 
DSS‑induced colitis. Nimesulide, a selective COX‑2 inhibitor, sup‑
pressed the histological changes induced by DSS without affecting 
inflammatory biomarkers; but when combined with zerumbone, 
it enhanced the protective effects.[103]
Saffron (番紅花 Fān Hóng Huā)
Saffron, scientifically known as Crocus sativus L. and be‑
longing to the family Iridaceae, is a perennial stemless herb 
widely cultivated in Iran, Pakistan, India, and Greece.[104‑106] The 
stigmas are the most important plant part and are dried and sold 
as saffron.[106] Saffron has been used to treat depression, cancer, 
and cardiac ailments. It is used in various traditional and folk 
systems of medicine in the Arabian countries and in the Indian 
subcontinent.[106‑109] Phytochemical studies have shown that the 
medicinal and organoleptic properties are due to the presence of 
crocetin [Figure 1], crocin, picrocrocin, and safranal.[106‑109] Cro‑
cetin, an important carotenoid of saffron, has been widely studied 
in the prevention and as a therapy for cancer.[110]
With respect to saffron’s effectiveness in UC, studies have 
shown that oral administration of crocetin to mice [Figure 1] (25‑
Figure 3. Indian medicinal plants reported to afford protection against inflammatory bowel disease in experimental studies
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100 mg/kg b. wt. per day) for 8 days significantly ameliorated 
TNBS‑induced UC.[111] The animals administered crocetin had 
reduced diarrhea and disruption of colonic architecture. Optimal 
effects were observed at 50 mg/kg/day dosage. Crocetin‑treated 
mice had reduced levels of NO, neutrophil infiltration, and lipid 
peroxidation in the inflamed colon, favorable expression of TH1 
and TH2 cytokines, and down‑regulation of NF‑κB. These observa‑
tions indicate that crocetin exerts beneficial effects in experimental 
UC.[111]
Malabar tamarind
Garcinia cambogia, also known as Malabar tamarind, is a plant 
mostly utilized in India and parts of southeast Asia for its culinary 
uses and therapeutic effects.[112, 113] The fruits, which are the most 
important part, resemble a miniature pumpkin and are used as an 
acidulant in the curries and to prepare sherbat. Its main component 
is hydroxycitric acid (HCA), which is an inhibitor of adenosine 
triphosphate (ATP) citrate lyase that reduces the biosynthesis of 
fatty acid and thus aids in weight reduction.[114,115] The decoction 
of the fruit is an essential preparation to treat ulcers and inflam‑
mation. It has been shown that the fruit extract possesses hypo‑
lipidemic properties and anti‑adipogenic and appetite‑suppressor 
effects.[116,117] A recent finding suggests that the extract blocked 
TNBS‑induced colitis in rats by preventing epithelial damage, 
decreasing the activity of MPO, decreasing the expression of 
COX‑2 and iNOS, reducing colonic PGE2 and IL‑1β levels, and 
reducing epithelial cell DNA damage.[117]
Fenugreek
Trigonella foenum‑graecum, colloquially known as fenugreek 
and belonging to the Fabaceae family, is an important dietary 
and medicinal agent.[118,119] The plants are native to India and 
northern Africa and have been used in the various traditional and 
folk systems of medicine to treat numerous indications, includ‑
ing labor induction, aiding digestion, and as a general tonic to 
improve metabolism and health.[119] Scientific studies have shown 
that fenugreek possesses pleiotropic actions and is useful in the 
amelioration of hypertension, cataract, inflammation, thyroid 
dysfunction, malaria, endothelial dysfunction, hyperlipidemia, 
and diabetes.[119]
With regard to its protective effects, animal studies in colitis 
have shown that saponin diosgenin [Figure 1], a compound in 
fenugreek, suppresses inflammation.[120]  Diosgenin was also 
found to suppress ovalbumin‑induced intestinal allergic reac‑
tion; gut inflammation, which reduced the frequency of diarrhea; 
infiltration and degranulation of mast cells; and increased the 
presence of mucin‑containing goblet cells in mice’s duodenum.[121] 
Furthermore, diosgenin reduced the crypt depth in the intestinal 
epithelium and inhibited systemic ovalbumin‑specific IgE and 
total IgE.[121] Another anti‑inflammatory property of diosgenin is 
that it suppresses TNF‑induced NF‑κB activation as determined 
by DNA binding, activation of IκBa kinase, IκBa phosphoryla‑
tion, IκBa degradation, p65 phosphorylation, and p65 nuclear 
translocation through Akt inhibition.[120] It also down‑regulated 
TNF‑induced expression of NF‑κB–regulated gene products 
involved in cell proliferation (cyclin D1, COX‑2, c‑myc) and 
anti‑apoptosis (IAP1, Bcl‑2, Bcl‑XL, Bfl‑1/A1, TRAF1, and 
cFLIP).[120]
Turmeric (薑黃Jiāng Huáng)
Curcuma longa Linn., a perennial shrub belonging to the family 
Zingiberaceae, is an indigenous plant of India, but is also cultivated 
in China, Sri Lanka, and other tropical countries nowadays.[122] 
The roots are the most important part of the plant and are used as 
a religious, culinary, and medicinal agent in India.[122] Turmeric 
is one of the highly investigated plants and studies have shown it 
to contain curcuminoids like curcumin [Figure 1],  Desmethoxyc‑
urcumin, bisdemethoxy curcumin, monodememthoxy curcumin, 
dihydro curcumin, and cyclocurcumin.[122] Curcumin has been 
shown to possess potent antioxidant,[123] anti‑inflammatory,[124] 
and cytoprotective effects.[125]
With respect to its protective effects in UC, numerous preclini‑
cal studies have shown that when administered orally or systemi‑
cally, either as a prophylactic or curative agent, curcumin improved 
the survival rate, and decreased the wasting and discomfort induced 
by various ulcerogens, such as DSS,[126‑130]  dinitrobenzene sulfonic 
acid (DNB),[131] dinitrochlorobenzene (DNCB),[132] TNBS,[133,134] 
acetic acid, and also in genetically predisposed IL‑10–knock‑
out[135,136] and mdr1a‑/‑ mice.[137,138] The results from these observa‑
tions have all been summarized in Table 1.
At the tissue level, curcumin decreased the macroscopic 
scores of mucosal erosions significantly.[139]   It has the property 
of scavenging the free radicals, influencing multiple signaling 
pathways, especially  involving the kinases, extracellular sig‑
naling kinase (AKT, MAPK, ERK), inhibiting COX‑1, COX‑2, 
lipoxygenase,[140] TNF‑α, IFN‑γ, iNOS, inhibiting transcription 
factors such as NF‑κβ and AP‑1, and modulating Nrf2‑dependent 
cytoprotective pathways.[137] Cumulatively, these studies strongly 
indicate that curcumin is a promising medication for improving 
remission in IBD patients and that randomized controlled clini‑
cal investigations in large cohorts of patients are needed to fully 
evaluate its clinical potential in the treatment of IBD.[137]
The most encouraging observations were accrued from a 
clinical study where curcumin (360 mg) reduced the relapse epi‑
sodes in patients with quiescent IBD, when administered three or 
four times a day for 3 months.[141] Additionally, recent studies by 
Suskind and coworkers have also shown that curcumin was well 
tolerated at a high dose by children with IBD. In the study, the 
investigators prescribed 500 mg of curcumin twice per day for 
3 weeks along with the standard therapy, and then by using the 
forced‑dose titration design enhanced the curcumin doses to 1 g 
twice per day at week 3 for a total of 3 weeks and then to 2 g twice 
per day at week 6 for 3 weeks. At the end of the study period, it 
was observed that all patients tolerated curcumin well and that the 
only untoward symptom observed was increase in flatulence. The 
authors also observed that combining curcumin with the standard 
therapy resulted in the improvement of Pediatric Crohn’s Disease 
Activity Index (PCDAI) or Pediatric Ulcerative Colitis Activity 
Index (PUCAI) score and suggested that curcumin may be useful 
as an adjunctive therapy in IBD.[142]
211
Saxena, et al. / Journal of Traditional and Complementary Medicine 4 (2014) 203‑217
PHYTOCHEMICALS WITH BENEFICIAL 
EFFECTS
Resveratrol
Resveratrol (3,5,4′‑trihydroxy‑trans‑stilbene) is a phyto‑
alexin produced by several plants including grapes, peanuts, 
mulberries, raspberries, and blueberries.[143,144] Its polyphenolic 
compound possesses multiple pharmacological benefits.[145,146] 
Preclinical studies provided evidence that resveratrol is effective 
in preventing DSS‑ and TNBS‑induced colitis in mice and rats, 
respectively.[145‑148] It was also shown that resveratrol (300 ppm) 
reduced the tumor burden of AOM + DSS‑induced colorectal 
inflammation and cancer in mice.[147]
In 2010, Sánchez‑Fidalgo and coworkers observed that mice 
fed with a diet enriched with 20 mg/kg of resveratrol for 30 days 
and administered 3% DSS for 5 days showed lower clinical scores, 
lower inflammation, and an increase in survival rate, as compared 
to the DSS‑treated mice which were fed control diet. Therefore, 
resveratrol can be linked to a better disease prognosis in case of 
acute UC. Subsequent studies have also shown the ability of resve‑
ratrol to halt the weight loss and reduce the colonic inflammation 
in mice treated with DSS[145,147] and rats treated with TNBS.[146] It 
also causes a concentration‑dependent reduction in inflammation.
Mechanistically, resveratrol decreases the percentage of 
neutrophils in the mesenteric lymph nodes and lamina pro‑
pria[147] and modulates the number of CD3 (+) T cells[147] and 
down‑regulates inflammatory and stress markers, namely p53 
Table 1. List of articles published on the protective effects afforded by curcumin in IBD in experimental animals with emphasis on the mechanism/s 
of action
Inducing agent Animal model reference Results and observations
Dextran sulfate 
sodium (DSS)
Swiss albino rats[126] Treatment with curcumin before DSS administration decreased the colonic bloody diarrhea and 
increased the colonic length as well as decreased hyperemia produced by DSS alone
A 37% reduction in the relative colonic weight/length ratio and reduction in severe submucosal 
edema, erosion, ulceration, inflammatory cell infiltration and crypt abscesses
46% decrease in the concentration of serum TNF‑α, 57% in MPO activity, 56% in lipid 
peroxidation and 65% in NO levels. 117% increase in GSH and 79% in GST
BALB/c mice[127] Curcumin reduced levels of MPO activity, number of infiltrating neutrophils, as well as CD4 and 
CD8 T cells and blocked NF‑κB activation in infiltrated inflammatory cells and epithelial cells
Dinitrobenzene 
sulfonic acid (DNB)
C3H mice[131] Curcumin attenuates activation of p38 MAPK and immunohistochemical studies confirmed that 
the effect was especially at the level of the mucosa
Dinitrochlorobenzene 
(DNCB)
Wistar rats[132] Treatment with NCB‑02 showed a dose dependent protection against DNCB‑induced colonic 
damage as indicated by normalization of colon length, reduction in colon weight both total and 
distal colons)
NCB‑02 at a dose 100 mg/kg b. wt. inhibited the DNCB‑induced expression of NFκ‑B and iNOS
Acetic acid Rats[163] Co‑administering curcumin decreased the activity of colonic MPO, levels of MDA and prevented 
programmed cell death
Curcumin restored immunreactivity of MAPKs in the colons of colitic rats
Trinitrobenzene 
Sulfonic Acid
BALB/c mice[164] Curcumin significantly reduced the loss in body weight, decreased the extent and severity of the 
injury of the large intestine
Curcumin pretreatment caused decrease in the elevated levels of both NO and superoxide 
production, decreased lipid peroxidation, MPO and serine protease activity
Curcumin pretreatment suppressed IFN‑γ and IL‑12 p40
The iNOS mRNA expression and the NF‑κB DNA binding activity was decreased by curcumin 
pretreatment
Rats[165] Curcumin therapy decreased the expression of proinflammatory and inflammatory cytokines and 
improved expression of PPARγ
Curcumin therapy decreased the expression of COX‑2 and increased the expression of PGE2 and 
J2 (15d‑PGJ2)
C57BL/6 mice[166] Reversed the effects of TNBS on Phex gene expression by attenuating the transcription of TNF‑α 




colon contraction in 
Sprague Dawley rats[167]
Curcumin had no effect on sensitivity of the colon to carbachol but reversed the decrease in 
carbachol‑induced contraction associated with trinitrobenzene sulphonic acid treatment
Tumor necrosis 
factor alpha TNF‑α
Male NMRI mice [168] Curcumin reduced the TNF‑α‑induced colitis in mice by decreasing the levels of 
myeloperoxidase, nitrites and malondialdehyde, and apoptosis
Transgenic animals IL‑10 knockout mice[135] Proximal and distal colon morphology showed a mild protective effect of curcumin only at 0.1%.
IL‑10 and curcumin act synergistically to downregulate NF‑κB activity in IEC and IL‑12/23p40 
production by splenocytes and dendritic cells
mdr1a‑/‑) mice[138] Curcumin alleviated colonic inflammation and reduced the histological injury
DNCB: Dinitrochlorobenzene, NMRI: National medical research institute; TNBS: Trinitrobenzene sulfonic; TNF: Tumor necrosis factor; GSH: Glutathione 
S‑transferase; IEC: Intestinal epithelial cells; GST: Glutathione S‑transferase; iNOS: Inducible Nitric oxide synthase; MPO: Myeloperoxidase
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and p53‑phospho‑Ser (15) proteins.[147] Resveratrol prevented 
the depletion of glutathione[146] and reduced the levels of 
MPO[145,146] and lipid peroxides in the colon,[145,146] concomi‑
tantly increasing the activities of SOD and GSH‑Px in the 
colonic tissue.[145]
• Furthermore, studies have been successful in showing a de‑
crease in the expression levels of TNF‑α,[145,147,148] IL‑1β,[148] 
IFN‑γ,[145,147] IL‑8,[145] p22(phox),[145] and gp91(phox),[145] and 
an increase in the levels of the anti‑inflammatory cytokine 
IL‑10[148] with resveratrol administration. Additionally, 
resveratrol also caused a reduction in the levels of PGE syn‑
thase‑1 (PGES‑1), COX‑2, and iNOS protein expressions 
by down‑regulation of p38‑mediated MAPK signaling 
pathway[148] and suppressing intercellular adhesion molecule 
1 (ICAM‑1) and vascular cell adhesion molecule 1 (VCAM‑1) 
levels in the colon and serum.[146]
Quercetin
Q u e r c e t i n  [ 2 ‑ ( 3 , 4 ‑ d i h y d r o x y p h e n y l ) ‑ 3 , 5 , 7 ‑ t r i ‑
hydroxy‑4H‑chromen‑4‑one] [Figure 1] is a flavonoid ubiquitously 
found in fruits, vegetables, leaves, and grains, and is one of the 
highly investigated phytochemicals.[149] It is a glycone form of a 
number of other flavonoid glycosides, such as rutin and quercitin, 
found in citrus fruit, buckwheat, and onions. Quercetin possesses 
many pharmacological benefits, including scavenging the free 
radicals, and has antioxidant and anti‑inflammatory properties.[150] 
Animal studies have shown that quercitin (1 and 5 mg/kg) is effec‑
tive when administered in the early stages (24 h) of TNBS‑induced 
colitis.[151] Biochemical end points showed that treatment with the 
flavonoids prevented an increase in colonic MDA, inhibited iNOS 
and alkaline phosphatase activities, but had no significant effects 
on observable damage. However, histopathologic observations 
showed no changes in the neutrophil infiltration.[151]
Kaempferol
T h e  f l a v a n o i d  k a e m p f e r o l  [ 3 , 5 , 7 ‑ t r i ‑
hydroxy‑2‑(4‑hydroxyphenyl)‑4H‑1‑benzopyran‑4‑one] [Figure 1] 
is ubiquitously present in many edible plants such as broccoli, cab‑
bage, kale, beans, endive, leek, tomato, strawberries, and grapes, 
and in plants or botanical products commonly used in traditional 
medicine (e.g. Ginkgo biloba, Tilia spp, Equisetum spp, Moringa 
oleifera, Sophora japonica, and propolis).[152] Myriad preclinical 
studies have shown that kaempferol and some of its glycosides 
have a wide range of pharmacological activities, including anti‑
cancer, antioxidant, anti‑inflammatory, antimicrobial, antidiabetic, 
anti‑osteoporotic, estrogenic/antiestrogenic, anxiolytic, analgesic, 
and antiallergic activities, and cardioprotective, and neuroprotec‑
tive activities.[153]
With regard to its role in UC treatment, recent studies by Park 
et al.[165] have shown that feeding kaempferol (0.1% or 0.3%) was 
effective in decreasing the DSS‑induced colitis in mice. They 
found lower levels of plasma leukotriene B4 (LTB4) in all the 
groups fed kaempferol, while the levels of NO and PGE2 and the 
activity of MPO in colonic mucosa were significantly decreased 
in 0.3% kaempferol pre‑ and post‑fed groups. Additionally, the 
level of  Trefoil factor 3 (TFF3) mRNA, a marker for goblet cell 
function, was up‑regulated in kaempferol pre‑fed animals indicat‑
ing its usefulness.[154]
Rutoside or rutin
R u t o s i d e ,  a l s o  k n o w n  a s  r u t i n ,  q u e r c e ‑
tin‑3‑O‑rutinoside, or sophorin, is a flavonol glyco‑
side between quercet in and the disaccharide rut in‑
ose [α‑l‑rhamnopyranosyl‑(1 → 6))‑β‑d‑glucopyranose] 
[Figure 1]. It is found in many plants such as buckwheat, 
tobacco, forsythia, hydrangea, and viola, and has important 
pharmacological effects.[155] Studies revealed that oral pre‑ and 
Figure 4. Molecular targets affected by various dietary agents and their phytochemicals in the prevention/amelioration of ulcerative colitis. ↑, increase; 
↓, decrease
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post‑treatment of rutoside (10 or 25 mg/kg) was effective in 
ameliorating TNBS‑induced colitis. It promoted colonic healing 
in rats[156] by increasing the levels of colonic glutathione and 
reducing the levels of colonic oxidative stress.[156] In another 
study, a diet containing 0.1% rutin, but not quercetin, ame‑
liorated 5% DSS‑induced body weight loss and shortening of 
the colorectum, and dramatically improved colitis histological 
scores in ICR mice.[157] Importantly, pretreatment with rutin for 
2 weeks or therapeutic post‑treatment for 4 days starting 3 days 
after DSS administration was shown to produce significant 
beneficial effects by attenuating proinflammatory gene expres‑
sion levels, namely IL‑1β and IL‑6, in colonic mucosa, in a 
dose‑dependent manner.[157]
Naringenin
One of the major polyphenols isolated from the citrus fruit is 
naringenin. It has been shown to possess nephro‑ and hepatopro‑
tective,[158] antioxidative,[159] anti‑inflammatory, and anticancer[160] 
properties, as suggested by several cell‑ and animal model–based 
studies. Naringenin was found to be effective in reducing the 
lead‑induced oxidative stress in rat models by increasing the 
activities of SOD, CAT, and GPx.[69,159] It reduces inflammation 
by inhibition of pro‑inflammatory cytokines NF‑κB and COX‑2 
and phosphorylation of transcription factor proto‑oncogene–en‑
coded AP‑1 in macrophages in lipopolysa ccharide (LPS)‑induced 
model.[161] Naringenin ameliorates the DSS‑induced colitis by 
reducing colonic damage, shortening the colon length, protect‑
ing the tight junction barrier, and decreasing pro‑inflammatory 
cytokines’ expression, especially those of IFN‑γ, Il‑6, MIP‑2, and 
IL‑17A.[162] These in vivo and in vitro studies make naringenin a 
strong contender for clinical studies for colitis and other related 
disease models.
CONCLUSIONS
A number of dietary supplements and phytochemicals are 
widely used in preventing or alleviating the symptoms of UC in 
experimental animal models [Graphical summary]. Studies on 
the efficacy and mechanism of various dietary plant extracts and 
pure phytochemicals in this field are reviewed and highlighted 
here [Figure 4]. Such evidence‑based updated information is 
very important for IBD patients and healthcare providers to make 
informed decisions about the benefits and limitations of the use 
of dietary bioactive compounds. We also emphasize the need 
for further clinical studies assessing the long‑term efficacy and 
safety of most commonly used dietary bioactives in UC. Stud‑
ies providing deeper mechanistic insights using in vitro systems 
and in vivo animal models will also be equally important to help 
develop better compounds or combination therapies ultimately 
aimed at the development of more optimized, robust, and safer 
treatment strategies in future based on natural dietary supple‑
ments and phytochemicals. There is a need for more clinical 
studies to declare these bioactive compounds as completely safe 
and effective.
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